Steris (STE) Liabilities from Discontinued Operations (2023 - 2024)
Steris (STE) recorded quarterly Liabilities from Discontinued Operations of 64012000.0 in Q1 2024, up 26.4% quarter-over-quarter from 50642000.0 in Q1 2023, and up 26.4% on a YoY basis from 50642000.0 in Q2 2023.
Steris (STE) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends
Steris' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 64012000.0 for Q1 2024.
- In Q1 2024, Liabilities from Discontinued Operations rose 26.4% year-over-year to 64012000.0; the TTM figure through Mar 2024 stood at 64012000.0 (up 26.4% YoY), while the FY2024 annual figure was 64012000.0, up 26.4% from the prior year.
- Liabilities from Discontinued Operations was 64012000.0 for Q1 2024 at Steris, up from 50642000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 64012000.0 in Q1 2024 to a low of 50642000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 64.01 Mn |
| Mar 31, 2024 | 64.01 Mn |
| Mar 31, 2023 | 50.64 Mn |
| Mar 31, 2023 | 50.64 Mn |